Clinical Trials
6 trialsNCT02453282 2026-05-12
MYSTIC
AstraZeneca
Phase 3 Active not recruiting
NCT03609047 2026-05-12
Appalaches
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Active not recruiting
NCT02542293 2026-05-01
NEPTUNE
AstraZeneca
Phase 3 Active not recruiting
NCT03003962 2026-03-11
Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
AstraZeneca
Phase 3 Active not recruiting
NCT05201547 2025-12-04
DOMENICA
ARCAGY/ GINECO GROUP
Phase 3 Active not recruiting
NCT03519971 2025-10-28
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer
AstraZeneca
Phase 3 Active not recruiting